Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2021 | Will liquid biopsies replace traditional risk factors in RCC?

Toni Choueiri, MD, Dana Farber Cancer Institute, Boston, MA, discusses whether liquid biopsy could replace traditional risk factors in renal cell carcinoma (RCC). A big challenge for the diagnosis of RCC is detecting the low level of ctDNA, for which liquid biopsy is a promising possible solution. This interview took place at the International Society of Liquid Biopsy (ISLB) 2021 Virtual Meeting.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.